Raju Prasad

Insider Reports History

Location
Boston, MA
Signature
/s/ Elizabeth Ryland Waldinger, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raju Prasad:

Company Role Class Num Shares Value Price $ Report Date Ownership
CRISPR Therapeutics AG Chief Financial Officer Common Shares 6,767 $407,305 $60.19 22 Jan 2026 Direct
CRISPR Therapeutics AG Chief Financial Officer Stock Option (Right to Buy) 41,667 22 Jan 2026 Direct
CRISPR Therapeutics AG Chief Financial Officer Restricted Stock Units 20,000 30 May 2025 Direct

Insider Reports Filed by Raju Prasad

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CRSP CRISPR Therapeutics AG 22 Jan 2026 3 -$525,979 4 Chief Financial Officer 26 Jan 2026, 17:35
CRSP CRISPR Therapeutics AG 06 Jan 2026 7 -$451,006 4 Chief Financial Officer 08 Jan 2026, 17:35
CRSP CRISPR Therapeutics AG 22 Dec 2025 3 -$559,549 4 Chief Financial Officer 23 Dec 2025, 17:33
CRSP CRISPR Therapeutics AG 03 Oct 2025 1 $0 4 Chief Financial Officer 03 Oct 2025, 17:36
CRSP CRISPR Therapeutics AG 30 May 2025 1 $0 4 Chief Financial Officer 03 Jun 2025, 21:45
CRSP CRISPR Therapeutics AG 20 Mar 2025 3 -$90,582 4 Chief Financial Officer 24 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 14 Mar 2025 5 -$157,252 4 Chief Financial Officer 18 Mar 2025, 17:35
CRSP CRISPR Therapeutics AG 16 Oct 2024 2 $0 4 Chief Financial Officer 18 Oct 2024, 17:35
CRSP CRISPR Therapeutics AG 20 Mar 2024 2 $0 4 Chief Financial Officer 22 Mar 2024, 17:45
CRSP CRISPR Therapeutics AG 14 Mar 2024 3 -$256,160 4 Chief Financial Officer 18 Mar 2024, 17:45
CRSP CRISPR Therapeutics AG 13 Oct 2023 1 $0 4 Chief Financial Officer 17 Oct 2023, 17:52
CRSP CRISPR Therapeutics AG 14 Mar 2023 2 $0 4 Chief Financial Officer 14 Mar 2023, 17:50
CRSP CRISPR Therapeutics AG 14 Mar 2023 0 $0 3 Chief Financial Officer 14 Mar 2023, 17:42